Pharmaceutical giants Johnson & Johnson and Sanofi have stopped a late-stage clinical trial for their experimental E.coli vaccine after results failed to demonstrate sufficient efficacy.

Johnson & Johnson (JNJ) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the ...

Speaker Mike Johnson (R-La.) didn’t rule out a full-year stopgap to keep the government funded through the end of the fiscal year, as lawmakers struggle to strike a bipartisan deal.

Johnson & Johnson (JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to about $143 per share. Several negative impacts were highlighted in the ...

Johnson's Lions offense under head coach Dan Campbell was second in yards, first in first downs and first in scoring. They were sixth in rushing and second in passing. Along the way, Johnson ...

Johnson & Johnson (NYSE:JNJ) is scheduled to announce Q4 earnings results on Wednesday, January 22nd, before market open. Analysts expect a profit per share of $2.02, which is a decline of 11.8% ...

Sheldon Timothy Herrington Jr., the man tried in court for allegedly killing Ole Miss student Jimmie "Jay" Lee, is expected to face a new charge just days after Lee's remains were discovered and ...

In a letter first obtained by Fox News Digital, Johnson wrote to the new president, "Thanks to your strong leadership and bold action in the first days of your presidency, the United States is ...